Blood brain barrier: An overview on strategies in drug delivery, realistic in vitro modeling and in vivo live tracking

Tissue Barriers

Volumn 4, Issue 1, 2016, Pages

  Pandey, Pawan Kumar ^a   Sharma, Ashok Kumar ^a   Gupta, Umesh ^a  

^a CENTRAL UNIVERSITY OF RAJASTHAN   (India)

Author keywords

blood brain barrier (BBB); brain on a chip; central nervous system; nanocarrier; strategies; tight junction

Indexed keywords

ANGIOPOIETIN; BONE MORPHOGENETIC PROTEIN; CELL PENETRATING PEPTIDE; CLAUDIN 5; CONANTOKIN G; DENDROTOXIN; G PROTEIN COUPLED RECEPTOR; INSULIN; LECTIN; LIPOPROTEIN; LYSOPHOSPHATIDIC ACID; NEUROPILIN 1; RETINAL DEHYDROGENASE; SEMAPHORIN; SONIC HEDGEHOG PROTEIN; SUPEROXIDE DISMUTASE; TAMOXIFEN; TETANUS TOXIN; TRANSFERRIN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; DRUG CARRIER;

ASTROCYTE; BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; CELL MEDIATED DELIVERY; DRUG DELIVERY SYSTEM; HUMAN; HYPERTHERMIC THERAPY; IN VITRO STUDY; IN VIVO STUDY; INTERSTITIAL FLUID; INTRACAROTID DRUG ADMINISTRATION; MIDDLE CEREBRAL ARTERY OCCLUSION; MODEL; NANOTECHNOLOGY; NONHUMAN; RECEPTOR MEDIATED TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSCYTOSIS; WEST NILE VIRUS; ANIMAL; CAPILLARY PERMEABILITY; DIAGNOSTIC IMAGING; DRUG EFFECTS; METABOLISM;

ANIMALS; BLOOD-BRAIN BARRIER; CAPILLARY PERMEABILITY; DRUG CARRIERS; HUMANS;

EID: 84981273787     PISSN: 21688362     EISSN: 21688370     Source Type: Journal    
DOI: 10.1080/21688370.2015.1129476     Document Type: Review

References (148)

1. W.Risau, H.Wolburg,. Development of blood–brain barrier. Trends Neurosci 1990; 13:174-78; PMID:1693235; http://dx.doi.org/10.1016/0166-2236(90)90043-A
2. N.J.Abbott, I.A.Romero. Transporting therapeutics across the blood–brain barrier. Mol Med Today 1996; 2:106-13
3. N.J.Abbott. Astrocyte–endothelial interactions and blood–brain barrier permeability. J Anat 2002; 200:629-638; PMID:12162730; http://dx.doi.org/10.1046/j.1469-7580.2002.00064.x
4. D.J.Begley, M.W.Brightman. Structural and functional aspects of the blood–brain barrier. Prog Drug Res 2003; 61:40-78
5. H.Wolburg, A.Lippoldt. Tight junctions of the blood–brain barrier: development, composition and regulation. Vasc Pharmacol 2002; 38:323-37; http://dx.doi.org/10.1016/S1537-1891(02)00200-8
6. B.T.Hawkins, T.P.Davis. The blood–brain barrier/ neurovascular unit in health and disease. Pharmacol Rev 2005; 57:173-85; PMID:15914466; http://dx.doi.org/10.1124/pr.57.2.4
7. J.M.Stenman, J.Rajagopal, T.J.Carroll, M.Ishibashi, J.McMahon, A.P.McMa-hon. Canonical Wnt signaling regulates organ-specific assemblyand differentiation of CNS vasculature. Science 2008; 322:1247-50; PMID:19023080; http://dx.doi.org/10.1126/science.1164594
8. S.Liebner, M.Corada, T.Bangsow, J.Babbage, A.Taddei, C.J.Czupalla, M.Reis, A.Felici, H.Wolburg, M.Fruttiger, et al. Wnt/beta-catenin signaling controls development of the blood–brain barrier. J Cell Biol 2008; 183:409-17; PMID:18955553; http://dx.doi.org/10.1083/jcb.200806024
9. R.Daneman, D.Agalliu, L.Zhou, F.Kuhnert, C.J.Kuo, B.A.Barres. Wnt/b-cateninsignaling is required for CNS, but not non-CNS, angiogenesis. Proc Nat Acad Sci USA 2009; 106:641-6; http://dx.doi.org/10.1073/pnas.0805165106
10. S.J.Tam, D.L.Richmond, J.S.Kaminker, Z.Modrusan, B.Martin-McNulty, T.C.Cao, R.M.Weimer, R.A.Carano, N.Bruggen, R.J.Watts. Death receptors DR6 and TROY regulate brain vascular development. Dev Cell 2012; 22:403-17
11. Y.Wang, A.Rattner, Y.Zhou, J.Williams, P.M.Smallwood, J.Nathans. Norrin/Frizzled4 signaling in retinal vascular development and bloodbrain barrier plasticity. Cell 2012; 151:1332-44; PMID:23217714; http://dx.doi.org/10.1016/j.cell.2012.10.042
12. A.Ben-Zvi, B.Lacoste, E.Kur, B.J.Andreone, Y.Mayshar, H.Yan, C.Gu. Mfsd2a is critical for the formation and function of the blood–brain barrier. Nature 2014; 22:507-11; http://dx.doi.org/10.1038/nature13324
13. A.Rodriguez, S.B.Tatter, W.Debinski. Neurosurgical techniques for disruption of the blood–brain barrier for glioblastoma treatment. Pharmaceutics 2015; 7:175-87; PMID:26247958; http://dx.doi.org/10.3390/pharmaceutics7030175
14. V.S.R.Atluri, M.Hidalgo, T.Samikkannu, K.R.V.Kurapati, R.D.Jayant, V.Sagar, M.P.N.Nair. Effect of human immunodeficiency virus on blood-brain barrier integrity and function: an update. Front Cell Neurosci 2015; 9:212; PMID:26113810; http://dx.doi.org/10.3389/fncel.2015.00212
15. V.C.Biancardi, S.J.Son, S.Ahmadi, J.A.Filosa, J.E.Stern. AngII-mediated BBB disruption in hypertension. Hypertension 2014; 63:572-79; PMID:24343120; http://dx.doi.org/10.1161/HYPERTENSIONAHA.113.01743
16. S.Won, I.Sayeed, B.L.Peterson, B.Wali, J.S.Kahn, D.G.Stein. Vitamin D prevents hypoxia/reoxygenation-induced blood-brain barrier disruption via Vitamin D receptor-mediated NF-kB signaling pathways. Plos One 2015; 10:1-17
17. S.Engelhardt, S.Patkar, O.O.Ogunshola. Cell-specific blood–brain barrier regulation in health and disease: a focus on hypoxia. Br J Pharmaco 2014; 171:1210-30; http://dx.doi.org/10.1111/bph.12489
18. M.P.H.Schreurs, C.A.Hubel, I.M.Bernstein, A.Jeyabalan, M.J.Cipolla. Increased oxidized low-density lipoprotein causes blood-brain barrier disruption in early-onset preeclampsia through LOX-1. FASEB J 2012; 27:1254-63; http://dx.doi.org/10.1096/fj.12-222216
19. A.Domínguez, B.Suárez-Merino, F.G.de-Cerio. J. Nanoparticles and blood-brain barrier: the key to central nervous system diseases. Nanosci Nanotechnol 2014; 14: 766-79; http://dx.doi.org/10.1166/jnn.2014.9119
20. A.E.-E.Aly, B.L.Waszczak. Intranasal gene delivery for treating Parkinson's disease: overcoming the blood–brain barrier. Expert Opin Drug Deliv 2015; 12:1-19; PMID:26289676; http://dx.doi.org/10.1517/17425247.2015.1069815
21. L.S.Covarrubias, L.M.Slosky, B.J.Thompson, T.P.Davis, P.T.Ronaldson. Transporters at CNS barrier sites: obstacles or opportunities for drug delivery? Curr Pharm Des 2014; 20:1422-49; PMID:23789948; http://dx.doi.org/10.2174/13816128113199990463
22. R.L.McCall, J.Cacaccio, E.Wrabel, M.E.Schwartz, T.P.Coleman, R.W.Sirianni. Pathogen-inspired drug delivery to the central nervous system, Tissue Barriers 2014; 2:e944449; PMID:25610755; http://dx.doi.org/10.4161/21688362.2014.944449
23. I.Wilhelm, I.A.Krizbai. In vitro models of the blood−brain barrier for the study of drug delivery to the brain. Mol Pharm 2014; 11:1949-63; http://dx.doi.org/10.1021/mp500046f
24. D.J.Bobilya. A model for transport studies of the blood–brain barrier. Methods Mol Biol 2010; 637:149-63; PMID:20419434; http://dx.doi.org/10.1007/978-1-60761-700-6_8
25. D.J.DiL, (ed.), E.H.Kerns (ed.). Blood-brain barrier in drug discovery: optimizing brain exposure of CNS drugs and minimizing brain side effects for peripheral drugs. New Jersey: John Wiley & Sons, 2015:167-379.
26. A.Burgess, K.Hynynen. Noninvasive and targeted drug delivery to the brain using focused ultrasound. ACS Chem Neurosci 2013; 4:519−26; PMID:23379618; http://dx.doi.org/10.1021/cn300191b
27. E.P.Costas, E.Y.Fenton, H.J.Caruncho. Reelin expression in brain endothelial cells: an electron microscopy study. BMC Neurosci 2015; 16:1-8; PMID:25655275; http://dx.doi.org/10.1186/s12868-015-0140-z
28. E.Salsano, G.Marotta, V.Manfredi, A.R.Giovagnoli, L.Farina, M.Savoiardo, D.Pareyson, R.Benti, G.Uziel. Brain fluorodeoxyglucose PET in adrenoleukodystrophy. Neurology 2014; 83:981-89; PMID:25098542; http://dx.doi.org/10.1212/WNL.0000000000000770
29. F.Chao, Y.Shen, H.Zhang, M.Tian. Multimodality molecular imaging of stem cells therapy for stroke. Bio Med Res Int 2013; 2013:1-16
30. H.Yan, L.Wang, J.Wang, X.Weng, H.Lei, X.Wang, L.Jiang, J.Zhu, W.Lu, X.Wei, C.Li. Two-order targeted brain tumor imaging by using an optical/paramagnetic nanoprobe across the blood brain barrier. ACS Nano 2012; 6:410-420; PMID:22148835; http://dx.doi.org/10.1021/nn203749v
31. I.M.Adanyeguh, D.Rinaldi, P.G.Henry, S.Caillet, R.Valabregue, A.Durr, F.Mochel. Triheptanoin improves brain energy metabolism in patients with Huntington disease. Neurology 2015; 84:490-5; PMID:25568297; http://dx.doi.org/10.1212/WNL.0000000000001214
32. P.A.Stewart, M.J.Wiley. Developing nervous tissue induces formation of blood–brain barrier characteristics in invading endothelial cells: a study using quail–chick transplantation chimeras. Dev Bio 1981; 84:183-92; http://dx.doi.org/10.1016/0012-1606(81)90382-1
33. Y.Olsson, I.Klatzo, P.Sourander, O.Steinwall. Blood–brain barrier to albumin in embryonic new born and adult rats. Acta Neuropathol 1968; 10:117-22; PMID:5707962; http://dx.doi.org/10.1007/BF00691305
34. M.Tauc, X.Vignon, C.Bouchaud. Evidence for the effectiveness of the blood–CSFbarrier in the fetal rat choroid plexus. A freeze-fracture and peroxidase diffusion study. Tissue Cell 1984; 16:65-74; PMID:6701893; http://dx.doi.org/10.1016/0040-8166(84)90019-3
35. N.R.Saunders. Development of the blood–brain barrier to macromolecules. In: M.B.Segal, ed. Barriers fluids eye brain. London: Macmillan Press; 1992.
36. T.Moos, K.Møllgård. Cerebrovascular permeability to azo dyes and plasma proteins in rodents of different ages. Neuropathol Appl Neurobiol 1993; 19:120-7; PMID:8316332; http://dx.doi.org/10.1111/j.1365-2990.1993.tb00416.x
37. R.F.Keep, S.R.Ennis, M.E.Beer, A.L.Betz. Developmental changes in blood–brainbarrier potassium permeability in the rat: relation to brain growth. J Physiol 1995; 488(Pt 2):439-48; PMID:8568682; http://dx.doi.org/10.1113/jphysiol.1995.sp020978
38. N.R.Saunders, G.W.Knott, K.M.Dziegielewska. Barriers in the immature brain. Cell Mol Neurobiol 2000; 20:29-40; PMID:10690500; http://dx.doi.org/10.1023/A:1006991809927
39. S.Liebner, K.H.Plate. Differentiation of the brain vasculature: the answer came blowing by the Wnt. J Angiogenes Res 2010; 2:1
40. D.Virgintino, M.Errede, D.Robertson, C.Capobianco, F.Girolamo, A.Vimercati, M.Bertossi, L.Roncali. Immunolocalization of tight junction proteins in the adult and developing human brain. Histochem Cell Biol 2004; 122:51-9; PMID:15221411; http://dx.doi.org/10.1007/s00418-004-0665-1
41. O.Grontoft. Intracranial haemorrhage and blood–brain barrier problems in the new-born; a pathologico-anatomical and experimental investigation. Acta Pathol Microbiol Scand Suppl 1954; 8:100-9
42. C.Hartmann, A.Zozulya, J.Wegener, H.J.Galla. The impact of glia-derived extracellular matrices on the barrier function of cerebralendothelial cells: an in vitro study. Exp Cell Res 2007; 313:1318-25; PMID:17346702; http://dx.doi.org/10.1016/j.yexcr.2007.01.024
43. Y.Serlin, I.Shelef, B.Knyazer, A.Friedman. Anatomy and physiology of the blood–brain barrier. Semin Cell Dev Biol 2015; 38:2-6; http://dx.doi.org/10.1016/j.semcdb.2015.01.002
44. S.Raab, H.Beck, A.Gaumann, A.Yuce, H.P.Gerber, K.Plate, H.P.Hammes, N.Ferrara, G.Breier. Impaired brain angiogenesis and neuronal apoptosis induced by conditional homozygous inactivation of vascular endothelial growth factor. Thromb Haemost 2004; 91:595-605; PMID:14983237
45. H.Gerhardt, M.Golding, M.Fruttiger, C.Ruhrberg, A.Lundkvist, A.Abramsson, M.Jeltsch, C.Mitchell, K.Alitalo, D.Shima, C.Betsholtz. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 2003; 161: 1163-77; PMID:12810700; http://dx.doi.org/10.1083/jcb.200302047
46. N.J.Abbott. Anatomy and physiology of the blood–brain barriers. In: M.Udenaes, E.C.M.de Lange, R.G.Thorne, editors. Drug Delivery to the Brain SE – 1, vol. 10. New York: Springer; 2014. pp. 3-21.
47. R.Nienke. N.R.Wevers, H.E. de Vries. Morphogens and blood-brain barrier function in health and disease. Tissue Barriers 2015
48. C.Gu, E.R.Rodriguez, D.V.Reimert, T.Shu, B.Fritzsch, L.J.Richards, A.L.Kolodkin, D.D.Ginty. Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development. Dev Cell 2003; 5:45-57; PMID:12852851; http://dx.doi.org/10.1016/S1534-5807(03)00169-2
49. J.I.Alvarez, A.D.Devillers, H.Kebir, I.Ifergan, P.J.Fabre, S.Terouz, M.Sabbagh, K.Wosik, L.Bourbonnière, M.Bernard et al. The Hedgehog pathway promotes blood–brain barrier integrityand CNS immune quiescence. Science 2011; 334:1727-31; PMID:22144466; http://dx.doi.org/10.1126/science.1206936
50. W.Risau, R.Hallmann, U.Albrecht. Differentiation dependent expression of proteins in brain endothelium during development of the blood brain barrier. Dev Biol 1986; 117:537-45; PMID:2875908; http://dx.doi.org/10.1016/0012-1606(86)90321-0
51. C.J.Ek, K.M.Dziegielewska, M.D.Habgood, N.R.Saunders. Barriers in the developing brain and Neurotoxicology. Neurotoxicology 2012; 33:586-604; PMID:22198708; http://dx.doi.org/10.1016/j.neuro.2011.12.009
52. A.Reyahi, A.M.Nik, M.Ghiami, A.G.Linde, F.Pontén, B.R.Johansson, P.Carlsson. Foxf2 is required for brain pericyte differentiationand development and maintenance of the blood-brain barrier. Dev Cell 2015; 6:19-32; http://dx.doi.org/10.1016/j.devcel.2015.05.008
53. M.R.Mizee, H.E.de Vries. Blood-brain barrier regulation. Tissue Barriers 2015; 1:5, e26882; http://dx.doi.org/10.4161/tisb.26882
54. N.J.Abbott. Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology. Neurochem Int 2004; 45:545-52; PMID:15186921; http://dx.doi.org/10.1016/j.neuint.2003.11.006
55. S.Nag, J.B.David. Blood Brain Barrier, Exchange of metabolites and gases. In H.Kalimo, editor, Pathology and Genetics: Cerebrovascular Diseases. Basel: ISN Neuropath Press. 2005. p.22-29.
56. R.C.Brown, K.S.Mark, R.D.Egleton, T.P.Davis. Protection against hypoxia-induced blood-brain barrier disruption: changes in intracellular calcium. Am J Physiol Cell Physiol 2004; 286:C1045-C1052; PMID:15075203; http://dx.doi.org/10.1152/ajpcell.00360.2003
57. H.Cserr, D.N.Cooper, P.K.Suri, C.S.Patlak. Efflux of radiolabeled polyethylene glycol and albumin from rat brain. Am J Physiol 1981; 240:F319-F328; PMID:7223889
58. H.F.Cserr, C.S.Patlak. Secretion and bulk flow of interstitial fluid. In: M.W.B.Bradbury (Ed.), Physiology and Pharmacology of the Blood–Brain Barrier. Heidelberg: Springer 1992; pp.245-61.
59. D.Dolman, S.Drndarski, N.J.Abbott, M.Rattray. Induction of aquaporin 1 but not aquaporin 4 messenger RNA in rat primary brain microvessel endothelial cells in culture. J Neurochem 2005; 93:825-33; PMID:15857386; http://dx.doi.org/10.1111/j.1471-4159.2005.03111.x
60. T.H.Milhorat, M.K.Hammock, J.D.Fenstermacher, V.A.Levin. Cerebrospinal fluid production by the choroid plexus and brain. Science 1971; 173:330-32; PMID:4997797; http://dx.doi.org/10.1126/science.173.3994.330
61. H.Davson, M.B.Segal. Physiology of the CSF and blood–brain barriers. Boca Raton, USA: CRC Press. 1995.
62. N.J.Abbott, L.Rönnbäck, E.Hansson. Astrocyte–endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006; 7:41-53; PMID:16371949; http://dx.doi.org/10.1038/nrn1824
63. E.R.Kandel, J.H.Schwartz, T.M.Jessel. Principles of Neural Science, 4th Ed. New York: McGraw-Hill, 2000. pp.1294.
64. M.Hammarlund-Udenaes, M.Fridén, S.Syvanen, A.Gupta. On the rate and extent of drug delivery to the brain. Pharm Res 2008; 25:1737-50; PMID:18058202; http://dx.doi.org/10.1007/s11095-007-9502-2
65. A.D.Wong, M.Ye, A.F.Levy, J.D.Rothstein, D.E.Bergles, P.C.Searson. The blood-brain barrier: an engineering perspective. Front Neuroeng 2013; 6:1-22; PMID:23443302; http://dx.doi.org/10.3389/fneng.2013.00007
66. C.Nicholson, P.K.Zare, L.Tao. Brain extracellular space as a diffusion barrier. Comput Vis Sci 2011; 14:309-25; PMID:23172993; http://dx.doi.org/10.1007/s00791-012-0185-9
67. A.K.Deo, F.P.Theil, J.M.Nicolas. Confounding parameters in preclinical assessment of blood-brain barrier permeation: an overview with emphasis on species differences and effect of disease states. Mol Pharm 2013; 10:1581-95; PMID:23256608; http://dx.doi.org/10.1021/mp300570z
68. B.O.Popescu, E.C.Toescu, L.M.Popescu, O.Bajenaru, D.F.Muresanu, M.Schultzberg, N.Bogdanovic. Blood-brain barrier alterations in ageing and dementia. J Neurol Sci 2009; 283:99-106
69. R.Daneman, L.Zhou, A.A.Kebede, B.A.Barres. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 2010; 468:562-6; PMID:20944625; http://dx.doi.org/10.1038/nature09513
70. Dorovini-Zis K., ed. The blood-brain barrier in health and disease, volume 2: pathophysiology and pathology. Boca Raton: CRC press, 2015; 5-6
71. G.J.Zoppo, K.Poeck, M.S.Pessin, S.M.Wolpert, A.J.Furlan, A.Ferbert, M.J.Alberts, J.A.Zivin, L.Wechsler, O.Busse, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992; 32:8-86
72. A.M.Wolka, J.D.Huber, T.P.Davis. Pain and the blood-brain barrier: obstacles to drug delivery. Adv Drug Deliv Rev 2003; 55:987-1006; PMID:12935941; http://dx.doi.org/10.1016/S0169-409X(03)00100-5
73. T.Nishioku, K.Furusho, A.Tomita, H.Ohishi, S.Dohgu, H.Shuto, A.Yamauchi, Y.Kataoka. Potential role for S100A4 in the disruption of the blood-brain barrier in collagen-induced arthritic mice, an animal model of rheumatoid arthritis. Neuroscience 2011; 189:286-92; PMID:21627981; http://dx.doi.org/10.1016/j.neuroscience.2011.05.044
74. J.M.Starr, J.Wardlaw, K.Ferguson, A.MacLullich, I.J.Deary, I.Marshall. Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging. J Neurol, Neurosurg Psychiat 2003; 74:70-6; PMID:12486269; http://dx.doi.org/10.1136/jnnp.74.1.70
75. J.H.Nguyen. Blood-brain barrier in acute liver failure. Neurochem Int 2012; 60:676-83; PMID:22100566; http://dx.doi.org/10.1016/j.neuint.2011.10.012
76. M.J.Cipolla, J.G.Sweet, S.L.Chan. Cerebral vascular adaptation to pregnancy and its role in the neurological complications of eclampsia. J Appl Physiol 2011; 110:329-39; PMID:21071591; http://dx.doi.org/10.1152/japplphysiol.01159.2010
77. J.P.Tang, A.Rakhit, F.L.Douglas, S.Melethil. Effect of chronic hypertension on the blood-brain barrier permeability of libenzapril. Pharm Res 1992; 9:236-43; PMID:1553348; http://dx.doi.org/10.1023/A:1018945608888
78. W.Y.Ong, B.Halliwell. Iron, atherosclerosis, and neurodegeneration: a key role for cholesterol in promoting iron-dependent oxidative damage? Ann NY Acad Sci 2004; 1012:51-64; http://dx.doi.org/10.1196/annals.1306.005
79. J.P.Patel and B.N.Frey. Disruption in the blood-brain barrier: the missing link between brain and body inflammation in bipolar disorder? Neural Plast 2015; 2015:1-12.
80. A.C.C.Fonseca, D.Matias, C.Garcia, R.Amaral, L.H.Geraldo, C.Freitas, F.R.S.Lima. The impact of microglial activation on blood-brain barrier in brain diseases. Front Cell Neurosci 2014; 8:362
81. J.Wen, J.Doerner, K.Weidenheim, Y.Xia, A.Stock, J.S.Michaelson, K.Baruch, A.Deczkowska, M.Gulinello, M.Schwartz, L.C.Burkly, C.Putterman. TNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL/lpr mice. J Autoimmun 2015; 60:40-50; PMID:25911200; http://dx.doi.org/10.1016/j.jaut.2015.03.005
82. J.A.Gorter, E.A.van Vliet, E.Aronica. Status epilepticus, blood–brain barrier disruption, inflammation, and epileptogenesis. Epilepsy Behav 2015; 49:13-6; PMID:25958228; http://dx.doi.org/10.1016/j.yebeh.2015.04.047
83. R.Paul, S.Lorenzl, U.Koedel, B.Sporer, U.Vogel, M.Frosch, H.W.Pfister. Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann Neurol 1998; 44:592-600; PMID:9778257; http://dx.doi.org/10.1002/ana.410440404
84. B.J.Kim, B.M.Hancock, A.Bermudez, N.D.Cid, E.Reyes, N.M.Sorge, X.Lauth, C.A.Smurthwaite, B.J.Hilton, A.Stotland, A.Banerjee, J.Buchanan, R.Wolkowicz, D.Traver, K.S.Doran. Bacterial induction of Snail1 contributes to blood-brain barrier disruption. J Clin Invest 2015; 125:2473-83; http://dx.doi.org/10.1172/JCI74159
85. B.Obermeier, R.Daneman, R.M.Ransohoff. Development, maintenance and disruption of the blood-brain barrier. Nat Med 2013; 19: 1584-96; PMID:24309662; http://dx.doi.org/10.1038/nm.3407
86. G.Tosi, L.Costantino, B.Ruozi, F.Forni, M.A.Vandelli. Polymeric nanoparticles for the drug delivery to the central nervous system. Exp OpinDrug Deliv 2008; 5:155-74; http://dx.doi.org/10.1517/17425247.5.2.155
87. L.Montenegro, A.Trapani, A.Latrofa, G.Puglisi. In vitro evaluation on a model of blood brain barrier of idebenone loaded solid lipid nanoparticles. J Nanosci Nanotechnol 2012; 12:330-7; PMID:22523983; http://dx.doi.org/10.1166/jnn.2012.5174
88. F.Re, I.Cambianica, C.Zona, S.Sesana, M.Gregori, R.Rigolio, B.L.Ferla, F.Nicotra, G.Forloni, A.Cagnotto. Functionalization of liposomes with ApoEderived peptides at different density affects cellular uptake and drug transport across a blood–brain barrier model. Nanomedicine 2011; 7:551-9; PMID:21658472; http://dx.doi.org/10.1016/j.nano.2011.05.004
89. M.Yemisci, Y.GürsoyÖzdemir, S.Caban, E.Bodur, Y.Capan, T.Dalkara. Transport of a caspase inhibitoracross the blood-brain barrier by chitosan nanoparticles. Methods Enzymol 2012; 508:253-69; PMID:22449930; http://dx.doi.org/10.1016/B978-0-12-391860-4.00013-6
90. S.Beg, A.Samad, M.I.Alam, I.Nazish. Dendrimers as novel systems for delivery of neuropharmaceuticals to the brain. CNS Neurol Disord Drug Targets 2011; 10:576-88; PMID:21631401; http://dx.doi.org/10.2174/187152711796235023
91. Y.Li, H.He, X.Jia, W.L.Lu, J.Lou, Y.Wei.A dual targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferring and tamoxifen for treating brain gliomas. Biomaterials 2012; 33:3899-908; PMID:22364698; http://dx.doi.org/10.1016/j.biomaterials.2012.02.004
92. S.V.Vinogradov, L.Y.Poluektova, E.Makarov, T.Gerson, M.T.Senanayake. NanoNRTIs: efficient inhibitors of HIV type1 in macrophages with a reduced mitochondrial toxicity. Antivir Chem Chemother 2010; 21:1-14; PMID:21045256; http://dx.doi.org/10.3851/IMP1680
93. Y.C.Chen, W.Y.Hsieh, W.F.Lee, D.T.Zeng. Effects of surface modification of PLGA–PEG–PLGA nanoparticles on loperamide delivery efficiency across the blood–brain barrier. J Biomater Appl 2011; 27:909-22; PMID:22207601; http://dx.doi.org/10.1177/0885328211429495
94. A.C.Silva, T.R.Oliveira, J.B.Mamani, S.M.Malheiros, L.Malavolta, L.F.Pavon, T.T.Sibov, E.AmaroJr, A.Tannus, E.L.Vidoto, et al. Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment. Int J Nanomed 2011; 6:591-603; PMID:21674016
95. H.Takagi, K.Azuma, T.Tsuka. Antitumor effects of hightemperature hyperthermia on a glioma rat model. Oncol Lett 2014; 7:1007-10; PMID:24944659
96. W.Titsworth, G.J.Murad, B.L.Hoh, M.Rahman. Fighting fire with fire: the revival of thermotherapy for gliomas. Anticancer Res 2014; 34:565-574; PMID:24510985
97. L.H.Treat, N.McDannold, N.Vykhodtseva, Y.Zhang, K.Tam, K.Hynynen. Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. Int J Cancer 2007; 121:901-7; PMID:17437269; http://dx.doi.org/10.1002/ijc.22732
98. D.C.Wang, Y.Zhang, H.Y.Chen, X.L.Li, L.J.Qin, Y.J.Li, H.Y.Zhang, S.Shuo Wang. Hyperthermia promotes apoptosis and suppresses invasion in C6 rat glioma cells. Asian Pacific J Cancer Prev 2012; 13:3239-45; http://dx.doi.org/10.7314/APJCP.2012.13.7.3239
99. M.Kiessling, E.Herchenhan, H.R.Eggert. Cerebrovascular and metabolic effects on the rat brain of focal Nd:YAG laser irradiation. J Neurosurg 1990; 73:909-17; PMID:2230973; http://dx.doi.org/10.3171/jns.1990.73.6.0909
100. M.Choi, T.Ku, K.Chong, J.Yoon, C.Choi. Minimally invasive molecular delivery into the brain using optical modulation of vascular permeability. Proc Natl Acad Sci USA 2011; 108: 9256-61; http://dx.doi.org/10.1073/pnas.1018790108
101. S.N.Tabatabaei, H.Girouard, A.S.Carret, S.Martel. Remote control of the permeability of the blood–brain barrier by magnetic heating of nanoparticles: A proof of concept for brain drug delivery. J Control Rel 2015; 206: 49-57; PMID:25724273; http://dx.doi.org/10.1016/j.jconrel.2015.02.027
102. L.Descamps, M.P.Dehouck, G.Torpier, R.Cecchelli. Receptor-mediated transcytosis of transferring through blood-brain barrier endothelial cells. Am J Physiol 1996; 270:1149-58;
103. B.Dehouck, L.Fenart, M.P.Dehouck, A.Pierce, G.Torpier, R.Cecchelli. A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier. J Cell Biol 1997; 138:877-89; PMID:9265653; http://dx.doi.org/10.1083/jcb.138.4.877
104. P.Candela, F.Gosselet, F.Miller, V.B.Scherrer, G.Torpier, R.Cecchelli, L.Fenart. Physiological pathway for low-density lipoproteins across the blood-brain barrier: transcytosis through brain capillary endothelial cells in vitro. Endothelium 2008; 15:254-64; PMID:19065317; http://dx.doi.org/10.1080/10623320802487759
105. N.S.Chung, K.M.Wasan. Potential role of the low-density lipoprotein receptor family as mediators of cellular drug uptake. Adv Drug Deliv Rev 2004; 56:1315-34; PMID:15109771; http://dx.doi.org/10.1016/j.addr.2003.12.003
106. X.Gao, J.Qian, S.Zheng, Y.Changyi, J.Zhang, S.Ju, J.Zhu, C.Li. Overcoming the blood brain barrier for delivering drugs into the brain by using adenosine receptor nanoagonist. ACS Nano 2014; 8:3678-89; PMID:24673594; http://dx.doi.org/10.1021/nn5003375
107. V.Sebbage. Cell-penetrating peptides and their therapeutic applications. Biosci Horizons 2009; 2:64-72; http://dx.doi.org/10.1093/biohorizons/hzp001
108. L.L.Zou, J.L.Ma, T.Wang, T.B.Yang, C.B.Liu. Cell-penetrating peptide-mediated therapeutic molecule delivery into the central nervous system. Curr Neuropharmacol 2013; 11:197-208; PMID:23997754; http://dx.doi.org/10.2174/1570159X11311020006
109. M.Roger, A.Clavreul, M.C.V.Julienne, C.Passirani, L.Sindji, P.Schiller, C.M.Menei, P.Menei. Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors. Biomaterials 2010; 31:8393-401; PMID:20688391; http://dx.doi.org/10.1016/j.biomaterials.2010.07.048
110. C.Fan, D.Wang, Q.Zhang, J.Zhou. Migration capacity of human umbilical cord mesenchymal stem cells towards glioma in vivo. Neural Regen Res 2013; 8:2093-102; PMID:25206518
111. A.Ebrahimi, N.Lalvand. Drug delivery using genetically modified mesenchymal stem cells: a promising targeted-delivery method. Hyg J Drugs Med 2013; 5:90-104
112. I.Gonda Systemic delivery of drugs to humans via inhalation. J Aerosol Med 2006, 19:47-53; PMID:16551214; http://dx.doi.org/10.1089/jam.2006.19.47
113. W.Ewart. The use of creosoted oil for the expulsion of tracheal false membranes after tracheotomy; and of intranasal injections of oil in various affection. Br Med J 1898; 1:1381-83; PMID:20757845; http://dx.doi.org/10.1136/bmj.1.1952.1381
114. S.Wu Intranasal delivery of neural stem cells: a CNS specific, non-invasive cell-based therapy for experimental autoimmune encephalomyelitis. J Clin Cell Immunol 2013; 1:4; PMID:24244890
115. H.Ueno, M.Mizuta, T.Shiiya, W.Tsuchimochi, K.Noma, N.Nakashima, M.Fujihara, M.Nakazato. Exploratory trial of intranasal administration of glucagon-like Peptide-1 in Japanese patients with type 2 diabetes. Diabetes Care 2014; 37:2024-27; PMID:24667460; http://dx.doi.org/10.2337/dc13-0690
116. S.I.Rapoport. Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications. Cell. Mol. Neurol. 2000; 20:217-30; http://dx.doi.org/10.1023/A:1007049806660
117. M.M.Miyake, B.S.Bleier. Bypassing the blood–brian barrier using established skull base reconstruction techniques. WJO 2015; 1:11-16
118. L.M.Griep, F.Wolbers, B.Wagenaar, P.M.Braak, B.B.Weksler, I.A.Romero, P.O.Couraud, I.Vermes, A.D.Meer, A.Berg. BBB on chip: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function. Biomed. Microdevices 2013; 15:145-50; http://dx.doi.org/10.1007/s10544-012-9699-7
119. R.Booth, H.Kim. Characterization of a microfluidic in vitro model of the blood brain barrier (mBBB). Lab Chip 2012; 12:1784-92; PMID:22422217; http://dx.doi.org/10.1039/c2lc40094d
120. G.Shayan, Y.S.Choi, E.V.Shusta, M.L.Shuler, K.H.Lee. Murine in vitro model of the blood-brain barrier for evaluating drug transport. Eur J Pharm Sci 2011; 42:148-55; PMID:21078386; http://dx.doi.org/10.1016/j.ejps.2010.11.005
121. G.Shayan, M.L.Shuler, K.H.Lee. The effect of astrocytes on the induction of barrier properties in aortic endothelial cells. Biotechnol Prog 2011; 27:1137-45; PMID:21626719; http://dx.doi.org/10.1002/btpr.620
122. Y.Molino, F.Jabès, E.Lacassagne, N.Gaudin, M.Khrestchatisky. Setting-up an in vitro model of rat blood-brain barrier (BBB): afocus on BBB impermeability and receptor-mediated transport. J Vis Exp 2014; 88:512-78
123. A.K.H.Achyuta, A.J.Conway, R.B.Crouse, E.C.Bannister, R.N.Lee, C.P.Katnik, A.A.Behensky, J.Cuevas, S.S.Sundaram. A modular approach to create a neurovascular unit-on-a-chip. Lab Chip 2013; 13:542-53; PMID:23108480; http://dx.doi.org/10.1039/C2LC41033H
124. M.Shi, D.Majumdar, Y.Gao B.M.Brewer, C.R.Goodwin, J.A.McLean, D.Li, D.J.Webb. Glia co-culture with neurons in microfluidic platforms promotes the formation and stabilization of synaptic contacts. Lab Chip 2013; 13:3008-21; PMID:23736663; http://dx.doi.org/10.1039/c3lc50249j
125. H.S.Park, S.Liu, J.McDonald, N.Thakor, I.H.Yang. Neuromuscular junction in a microfluidic device. Conf IEEE Eng Med Biol Soc 2013:2833-35
126. L.Ziegler, S.Grigoryan, I.H.Yang, N.V.Thakor,, R.S.Goldstein. Efficient generation of schwann cells from human embryonic stem cell-derived neurospheres. Stem Cell Rev 2011; 7:394-403; PMID:21052870; http://dx.doi.org/10.1007/s12015-010-9198-2
127. A.Kunze, S.Lengacher, E.Dirren, P.Aebischer, P.J.Magistrettic, P.Renaud. Astrocyte-neuron co-culture on microchips based on the model of SOD mutation to mimic ALS. Integr Biol (Camb) 2013; 5:964-75; PMID:23695230; http://dx.doi.org/10.1039/c3ib40022k
128. K.Roe, B.Orillo, S.Verma. West nile virus-induced cell adhesion molecules on human brain microvascular endothelial cells regulate leukocyte adhesion and modulate permeability of the in vitro blood-brain barrier model. Plos One 2014; 9:1-12; http://dx.doi.org/10.1371/journal.pone.0102598
129. X.Xiong, Y.Sun, A.Sattiraju, Y.Jung, A.Mintz, S.Hayasaka, K.C.P.Li. Remote spatiotemporally controlled and biologically selective permeabilization of blood-brain barrier. J Control Release 2015; 217:113-20; PMID:26334482
130. L.Cucullo, N.Marchi, M.Hossain, D.Janigro. A dynamic in vitro BBB model for the study of immune cell trafficking into the central nervous system. J Cereb Blood Flow Metab 2011; 31:767-77; PMID:20842162
131. C.J.Czupalla, S.Liebner, K.Devraj. In vitro models of the blood-brain barrier. Methods Mol Biol 2014; 1135:415-37; PMID:24510883
132. A.Wolff, M.Antfolk, B.Brodin, M.Tenje. In vitro blood–brain barrier models—An overview of established models and new microfluidic approaches. J Pharm Sci 2015; 104:2727-46.
133. T.T.Wager, J.L.Liras, S.Mente, P.Trapa. Strategies to minimize CNS toxicity: in vitro high throughput assays and computational modeling. Expert Opin Drug Metab Toxicol 2012;8: 531-42.
134. T.Ruck, S.Bittner, S.G.Meuth. Blood brain barrier modeling: challenges and perspectives. Neural Regen Res 2015;10:889-91.
135. O.Prager, Y.Chassidim, C.Klein, H.Levi, I.Shelef, A.Friedman. Dynamic in vivo imaging of cerebral blood flow and blood–brain barrier permeability. Neuroimage 2010; 49:337-44.
136. J.Greenwood, J.Adu, A.J.Davey, N.J.Abbott, M.W.Bradbury. The effect of bile salts on the permeability and ultrastructure of the perfused, energy-depleted, rat blood–brain barrier. Off J Int Soc Cereb Blood Flow Metabol 1991; 11:644-54.
137. B.D.Watson, W.D.Dietrich, R.Prado, M.D.Ginsberg. Argon laser-induced arterial photo thrombosis. J Neurosurg 1987; 66:748-54.
138. A.K.Dunn. Laser speckle contrast imaging of cerebral blood flow. Ann Biomed Eng 2012; 40:367-77.
139. A.Wunder, J.Klohs, U.Dirnagl. Non-invasive visualization of CNS inflammation with nuclear and optical imaging. Neuroscience 2009; 158:1161-73.
140. V.W.Pike. PET radiotracers: crossing the blood-brain barrier and surviving metabolism. Trends Pharmacol Sci 2009; 30:431-40.
141. D.J.Wolak, M.E.Pizzo, R.G.Thorne. Probing the extracellular diffusion of antibodies in brain using in vivo integrative optical imaging and ex vivo fluorescence imaging. J Control Release 2015; 197:78-86.
142. V.Josserand, H.Pélerin, B.de Bruin, B.Jego, B.Kuhnast, F.Hinnen, F.Ducongé, R.Boisgard, F.Beuvon, F.Chassoux, et al. Evaluation of drug penetration into the brain: a double study by in vivo imaging with positron emission tomography and using an in vitro model of the human blood-brain barrier. J Pharmacol Exp Ther 2006; 316:79-86.
143. D.J.Wolak, R.G.Thorne. Diffusion of macromolecules in the brain: implications for drug delivery. Mol Pharm 2013; 10:1492-1504.
144. E.Sykova, C.Nicholson. Diffusion in brain extracellular space. Physiol Rev 2008; 88:1277-1340.; http://dx.doi.org/10.1152/physrev.00027.2007
145. C.Nicholson, L.Tao. Hindered diffusion of high molecular weight compounds in brain extracellular microenvironment measured with integrative optical imaging. Biophys J 1993; 65:2277-90.
146. R.G.Thorne, S.Hrabetova, C.Nicholson. Diffusion of epidermal growth factor in rat brain extracellular space measured by integrative optical imaging. J Neurophysiol 2004; 92:3471-81; http://dx.doi.org/10.1152/jn.00352.2004
147. M.Aswendt, N.Henn, S.Michalk, G.Schneider, M.S.Steiner, U.Bissa, C.Dose, M.Hoehn. Novel bimodal iron oxide particles for efficient tracking of human neural stem cells in vivo. Nanomedicine 2015; 10; 16:2499-512.; http://dx.doi.org/10.2217/nnm.15.94
148. Y.Yin, X.Zhou, X.Guan, Y.Liu, C.Jiang, J.Liu. In vivo tracking of human adipose-derived stem cells labeled with ferumoxytol in rats with middle cerebral artery occlusion by magnetic resonance imaging. Neural Regener Res 2015; 10:909-15; http://dx.doi.org/10.4103/1673-5374.158355